l General Information |
Product Name | Cefodizime sodium |
General description | Cefodizime Sodium is the sodium salt form of cefodizime, a third-generation, aminothiazolyl cephalosporin for parenteral use. |
Synonym | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazoly (methoxyimino)acetyl}-3-[[[5-(carboxymethyl)-4-methyl-2-thiazilyl]-8-oxo-, sodium salt (1:2), (6R,7R)-; Kenicef |
Purity | ≥98.0%(HPLC) | CAS Number | 86329-79-5 |
Formula | C20H18N6Na2O7S4 | Molecular Weight | 628.63 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | ≥50mg/mL |
l Biological Information |
Biochem/Physiol Actions | Cefodizime Sodium is the sodium salt form of cefodizime, a third-generation, aminothiazolyl cephalosporin for parenteral use. Cefodizime has broad-spectrum activity and is stable to most beta-lactamases. |
Application | Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. |
l Packaging & Storage |
Packaging | 250mg; 1g |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
